Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, July 26, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Lab Relocation Specialist Expands Turnkey Solution
Friday, March 07, 2014
Specialist laboratory relocation expert, Andrew Porter Limited, has further expanded its service portfolio.

Malvern Announces Guest Presenter for March 18th Protein Characterization Webinar
Thursday, March 06, 2014
Renowned protein scientist Prof. Dr. John F. Carpenter shows how combining DLS with Raman Spectroscopy delivers new insights in protein stability, aggregation and structure.

New HPLC Column Separates Challenging Glycan Isomers
Wednesday, March 05, 2014
Company will showcase the GlycanPac AXR-1 column at Pittcon 2014.

Abcam Introduces Alexa Fluor® 680/790 Secondary Antibodies
Tuesday, March 04, 2014
New range offers high performance antibodies for more efficient western blotting.

Malvern Instruments Shows NanoSight NTA at BioNanoMed 2014
Saturday, March 01, 2014
BioNanoMed 2014 to be held in Krems, Austria from 26 - 28 March.

384-Well Reagent Reservoirs from INTEGRA
Friday, February 28, 2014
Reagent reservoirs offer maximum liquid recovery.

Lightweight Electronic Pipettes
Tuesday, February 18, 2014
The new VIAFLO II multichannel electronic pipette range from INTEGRA combines ultra lightweight design and unsurpassed operation comfort enabling users to improve efficiency in their working environment.

Bio-Rad Introduces Bio-Plex Manager™ MP Software Upgrade for All MAGPIX Multiplex Readers
Friday, February 14, 2014
Bio-Rad Laboratories, Inc. announce the release of its Bio-Plex Manager MP Software Upgrade, which runs on all Luminex-based MAGPIX readers.

Protea Announces Release of New Gel Protein Recovery System
Thursday, February 13, 2014
The Gel Protein Recovery GPR-850 System enables intact protein recovery from polyacrylamide gels for top-down proteomics applications.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1224
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv